A detailed history of R.M.Sincerbeaux Capital Management LLC transactions in Viatris Inc stock. As of the latest transaction made, R.M.Sincerbeaux Capital Management LLC holds 159,904 shares of VTRS stock, worth $2 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
159,904
Previous 159,867 0.02%
Holding current value
$2 Million
Previous $1.7 Million 9.24%
% of portfolio
1.16%
Previous 1.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.32 - $12.13 $381 - $448
37 Added 0.02%
159,904 $1.86 Million
Q2 2024

Aug 13, 2024

SELL
$10.05 - $12.02 $371 - $444
-37 Reduced 0.02%
159,867 $1.7 Million
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $14,269 - $16,888
-1,488 Reduced 0.92%
159,904 $1.58 Million
Q2 2023

Jul 25, 2023

SELL
$9.02 - $10.29 $14,432 - $16,464
-1,600 Reduced 0.98%
161,392 $1.61 Million
Q4 2022

Feb 03, 2023

SELL
$8.72 - $11.56 $505,472 - $670,098
-57,967 Reduced 26.23%
162,992 $1.81 Million
Q3 2022

Nov 10, 2022

SELL
$8.48 - $11.13 $9,879 - $12,966
-1,165 Reduced 0.52%
220,959 $1.88 Million
Q2 2022

Aug 02, 2022

SELL
$9.95 - $12.27 $199 - $245
-20 Reduced 0.01%
222,124 $2.33 Million
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $6,494 - $10,194
-662 Reduced 0.3%
222,144 $2.42 Million
Q4 2021

Feb 08, 2022

BUY
$12.09 - $14.68 $1.11 Million - $1.34 Million
91,500 Added 69.68%
222,806 $3.02 Million
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $9,275 - $10,591
-700 Reduced 0.53%
131,306 $1.78 Million
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $3,216 - $4,005
-248 Reduced 0.19%
132,006 $1.89 Million
Q4 2020

Feb 11, 2021

BUY
$14.3 - $18.74 $1.89 Million - $2.48 Million
132,254 New
132,254 $2.48 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track R.M.Sincerbeaux Capital Management LLC Portfolio

Follow R.M.Sincerbeaux Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R.M.Sincerbeaux Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on R.M.Sincerbeaux Capital Management LLC with notifications on news.